Cogstate Limited (ASX:CGS)
Australia · Delayed Price · Currency is AUD 2.700
+0.030 (1.12%)
Aug 11, 2026, 4:10 PM AEST
Cogstate Financials Overview
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 56.07 | 53.09 | 43.43 | 40.45 | 44.98 | 32.7 |
Revenue Growth | 5.61% | 22.25% | 7.36% | -10.07% | 37.57% | 43.59% |
Gross Profit Gross Profit Growth | 31.66 | 32.14 | 24.3 | 20.65 | 26.28 | 17.49 |
Operating Income Operating Income Growth | 12.85 | 13.16 | 6.17 | 2.29 | 10.95 | 3.84 |
Net Income Net Income Growth | 10.78 | 10.14 | 5.45 | 3.57 | 7.52 | 5.23 |
Earnings Per Share EPS Growth | 0.06 | 0.06 | 0.03 | 0.02 | 0.04 | 0.03 |
EPS Growth | 5.35% | 85.08% | 55.94% | -52.47% | 40.73% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Clinical Trials (incl. Precision Recruitment Tool & Research) Clinical Trials (incl. Precision Recruitment Tool & Research) Growth | 53.59 | 50.58 | 39.44 | 36.05 | - | - |
Healthcare (Incl. Sport) Healthcare (Incl. Sport) Growth | 2.48 | 2.51 | 3.99 | 4.4 | 4.46 | 3.76 |
Total Total Growth | 56.07 | 53.09 | 43.43 | 40.45 | 45.03 | 32.7 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 34.05 | 35.56 | 30.12 | 28.68 | 30.6 | 23.64 |
Total Debt Total Debt Growth | 0.42 | 0.47 | 0.67 | 0.38 | 1.41 | 1.74 |
Net Cash (Debt) Net Cash Growth | 33.64 | 35.09 | 29.45 | 28.3 | 29.19 | 21.9 |
Net Cash Growth | -4.16% | 19.16% | 4.08% | -3.04% | 33.26% | 314.90% |
Net Cash Per Share Net Cash Per Share Growth | 0.19 | 0.20 | 0.17 | 0.16 | 0.17 | 0.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8.83 | 11.48 | 5.78 | 0.65 | 9.73 | 16.11 |
Capital Expenditures CapEx Growth | -0.49 | -0.3 | -0.45 | -0.13 | -0.42 | -0.63 |
Free Cash Flow Free Cash Flow Growth | 8.34 | 11.18 | 5.33 | 0.52 | 9.3 | 15.49 |
Free Cash Flow Growth | -25.40% | 109.57% | 920.38% | -94.38% | -39.93% | 6936.90% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 56.47% | 60.53% | 55.96% | 51.04% | 58.43% | 53.50% |
Operating Margin | 22.91% | 24.78% | 14.21% | 5.67% | 24.34% | 11.75% |
Pretax Margin | 25.02% | 26.20% | 16.35% | 7.48% | 23.77% | 17.80% |
Profit Margin | 19.22% | 19.11% | 12.55% | 8.82% | 16.72% | 16.01% |
FCF Margin | 14.87% | 21.05% | 12.28% | 1.29% | 20.68% | 47.37% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.020 | 0.013 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.75% | 1.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 29.32 | 19.05 | 23.42 | 53.31 | 24.22 | 33.32 |
Forward PE | 22.37 | 21.00 | 30.85 | 33.07 | 20.83 | 35.45 |
P/FCF Ratio | 36.69 | 17.29 | 23.93 | 363.85 | 19.58 | 11.26 |
PS Ratio | 5.46 | 3.64 | 2.94 | 4.70 | 4.05 | 5.33 |